BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
40.92
+0.65 (1.61%)
At close: Mar 6, 2026

SHA:688166 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-765.35998.051,180336.84
Trading Asset Securities
--50.6250.120.76
Cash & Short-Term Investments
606.22765.351,0491,230337.6
Cash Growth
-20.79%-27.02%-14.78%264.48%-35.02%
Accounts Receivable
-339.5308.88307.47373.85
Other Receivables
-6.6619.9118.783.75
Receivables
-346.17328.79326.25377.59
Inventory
-364.61344.63280.35200.06
Prepaid Expenses
--3.655.834.48
Other Current Assets
-164.1411495.3973.27
Total Current Assets
-1,6401,8401,938993.01
Property, Plant & Equipment
-2,7052,4892,0761,378
Long-Term Investments
-437.06425.86399.33348.28
Goodwill
-3.127.57.57.5
Other Intangible Assets
-89.4893.6681.6480.84
Long-Term Accounts Receivable
-2.1---
Long-Term Deferred Tax Assets
-73.5542.2823.9419.86
Long-Term Deferred Charges
-57.4930.1826.8725.83
Other Long-Term Assets
-156.03104.09107.73115.86
Total Assets
-5,1645,0324,6612,970
Accounts Payable
-266228.18252.19211.89
Accrued Expenses
-75.572.3169.0461.72
Short-Term Debt
-115.26156.87124.38257.05
Current Portion of Long-Term Debt
-516.96397.93313.8716.58
Current Portion of Leases
-13.6916.11.349.87
Current Income Taxes Payable
-16.6814.0414.973.69
Current Unearned Revenue
-28.022429.4920.33
Other Current Liabilities
-20.2712.816.261.93
Total Current Liabilities
-1,052922.25811.52583.07
Long-Term Debt
-1,5801,6151,576618.69
Long-Term Leases
-10.2121.016.010.22
Long-Term Unearned Revenue
-74.7126.252626
Other Long-Term Liabilities
-1029.82--
Total Liabilities
-2,7272,6142,4201,228
Common Stock
-422.47422.47422.47410
Additional Paid-In Capital
-982.361,0571,008738.94
Retained Earnings
-1,046897.66743.35555.05
Treasury Stock
--10.01---
Comprehensive Income & Other
--46.48-8.6417.77-25.8
Total Common Equity
2,4482,3952,3692,1921,678
Minority Interest
-42.7348.9750.0463.45
Shareholders' Equity
2,5322,4372,4182,2421,742
Total Liabilities & Equity
-5,1645,0324,6612,970
Total Debt
2,3412,2362,2072,022902.42
Net Cash (Debt)
-1,735-1,470-1,158-791.15-564.82
Net Cash Per Share
-4.02-3.50-2.75-1.91-1.39
Filing Date Shares Outstanding
466.81422.11422.1422.47410
Total Common Shares Outstanding
466.81422.11422.47422.47410
Working Capital
-587.89917.491,127409.94
Book Value Per Share
6.135.675.615.194.09
Tangible Book Value
2,3582,3022,2672,1031,590
Tangible Book Value Per Share
5.915.455.374.983.88
Buildings
-728.65261.26273.4104.72
Machinery
-1,122704.8318.41287.37
Construction In Progress
-1,1671,7361,6661,131
Source: S&P Global Market Intelligence. Standard template. Financial Sources.